Cargando…

Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs

AIMS/HYPOTHESIS: Current drug labels for thiazolidinediones (TZDs) warn of increased fractures, predominantly for distal fractures in women. We examined whether exposure to TZDs affects hip fracture in women and men and compared the risk to that found with other drugs used in diabetes. METHODS: Usin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colhoun, H. M., Livingstone, S. J., Looker, H. C., Morris, A. D., Wild, S. H., Lindsay, R. S., Reed, C., Donnan, P. T., Guthrie, B., Leese, G. P., McKnight, J., Pearson, D. W. M., Pearson, E., Petrie, J. R., Philip, S., Sattar, N., Sullivan, F. M., McKeigue, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464390/ https://www.ncbi.nlm.nih.gov/pubmed/22945303 http://dx.doi.org/10.1007/s00125-012-2668-0

Ejemplares similares

Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study
por: Bell, Samira, et al.
Publicado: (2017)

Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme
por: Looker, H. C., et al.
Publicado: (2013)

Contemporary Risk of Hip Fracture in Type 1 and Type 2 Diabetes: A National Registry Study From Scotland†
por: Hothersall, Eleanor J, et al.
Publicado: (2014)

End-stage renal disease and survival in people with diabetes: a national database linkage study
por: Bell, S., et al.
Publicado: (2015)

Cohort profile: the Scottish Diabetes Research Network national diabetes cohort – a population-based cohort of people with diabetes in Scotland
por: McGurnaghan, Stuart J., et al.
Publicado: (2022)

Risk of Cardiovascular Disease and Total Mortality in Adults with Type 1 Diabetes: Scottish Registry Linkage Study
por: Livingstone, Shona J., et al.
Publicado: (2012)

Use of personalised risk-based screening schedules to optimise workload and sojourn time in screening programmes for diabetic retinopathy: A retrospective cohort study
por: Ochs, Andreas, et al.
Publicado: (2019)

Time trends in deaths before age 50 years in people with type 1 diabetes: a nationwide analysis from Scotland 2004–2017
por: O’Reilly, Joseph E., et al.
Publicado: (2020)

Glycaemic control trends in people with type 1 diabetes in Scotland 2004–2016
por: Mair, Colette, et al.
Publicado: (2019)

Research: Treatment Factors associated with statin treatment for the primary prevention of cardiovascular disease in people within 2 years following diagnosis of diabetes in Scotland, 2006–2008
por: Jones, N R V, et al.
Publicado: (2014)

The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes
por: Höhn, Andreas, et al.
Publicado: (2021)

Reduced Incidence of Lower-Extremity Amputations in People With Diabetes in Scotland: A nationwide study
por: Kennon, Brian, et al.
Publicado: (2012)

Rates of referable eye disease in the Scottish National Diabetic Retinopathy Screening Programme
por: Looker, H C, et al.
Publicado: (2014)

Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety Study
por: Wang, Huan, et al.
Publicado: (2023)

Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland
por: Looker, H. C., et al.
Publicado: (2012)

Microvascular disease in diabetes and severe COVID-19 outcomes – Authors' reply
por: Colhoun, Helen M, et al.
Publicado: (2021)

Effect of Socioeconomic Status on Mortality Among People With Type 2 Diabetes: A study from the Scottish Diabetes Research Network Epidemiology Group
por: Walker, Jeremy J., et al.
Publicado: (2011)

Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland
por: Jeyam, Anita, et al.
Publicado: (2021)

Achieved Levels of HbA(1c) and Likelihood of Hospital Admission in People With Type 1 Diabetes in the Scottish Population: A study from the Scottish Diabetes Research Network Epidemiology Group
por: Govan, Lindsay, et al.
Publicado: (2011)

Predicting renal disease progression in a large contemporary cohort with type 1 diabetes mellitus
por: Colombo, Marco, et al.
Publicado: (2019)

Flash monitor initiation is associated with improvements in HbA(1c) levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide observational study
por: Jeyam, Anita, et al.
Publicado: (2021)

Utilisation trends of rosiglitazone and pioglitazone in Australia before and after safety warnings
por: Niyomnaitham, Suvimol, et al.
Publicado: (2014)

Ethnic Differences in Glycaemic Control in People with Type 2 Diabetes Mellitus Living in Scotland
por: Negandhi, Preeti H., et al.
Publicado: (2013)

Type 2 diabetes, socioeconomic status and life expectancy in Scotland (2012–2014): a population-based observational study
por: Walker, Jeremy, et al.
Publicado: (2017)

Development of Heart Failure in Medicaid Patients with Type 2 Diabetes Treated with Pioglitazone, Rosiglitazone, or Metformin
por: Breunig, Ian M., et al.
Publicado: (2014)

Development and validation of a cardiovascular risk prediction model in type 1 diabetes
por: McGurnaghan, Stuart J., et al.
Publicado: (2021)

Stress Hyperglycaemia in Hospitalised Patients and Their 3-Year Risk of Diabetes: A Scottish Retrospective Cohort Study
por: McAllister, David A., et al.
Publicado: (2014)

Rosiglitazone and Pioglitazone Alter Aromatase Kinetic Properties in Human Granulosa Cells
por: Araki, Takako, et al.
Publicado: (2011)

Rosiglitazone and Pioglitazone Utilization from January 2007 Through May 2008 Associated With Five Risk-Warning Events
por: Starner, Catherine I., et al.
Publicado: (2008)

Pioglitazone versus Rosiglitazone: Effects on Lipids, Lipoproteins, and Apolipoproteins in Head-to-Head Randomized Clinical Studies
por: Deeg, Mark A., et al.
Publicado: (2008)

Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013
por: Read, Stephanie H., et al.
Publicado: (2016)

Comparison of serum and urinary biomarker panels with albumin/creatinine ratio in the prediction of renal function decline in type 1 diabetes
por: Colombo, Marco, et al.
Publicado: (2020)

Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study
por: McKeigue, Paul M, et al.
Publicado: (2022)

Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study
por: Juurlink, David N, et al.
Publicado: (2009)

Amputation-free survival in 17,353 people at high risk for foot ulceration in diabetes: a national observational study
por: Vadiveloo, Thenmalar, et al.
Publicado: (2018)

The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: real-world evidence on thiazolidinedione safety
por: Leonard, Charles E., et al.
Publicado: (2020)

Genome-wide aggregated trans-effects on risk of type 1 diabetes: A test of the “omnigenic” sparse effector hypothesis of complex trait genetics
por: Iakovliev, Andrii, et al.
Publicado: (2023)

Large socioeconomic gap in period life expectancy and life years spent with complications of diabetes in the Scottish population with type 1 diabetes, 2013–2018
por: Höhn, Andreas, et al.
Publicado: (2022)

Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database
por: Berthet, Stephanie, et al.
Publicado: (2011)

Influence of health warnings on the use of rosiglitazone and pioglitazone in an area of Spain: A time-series study
por: Carracedo-Martínez, Eduardo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lru7pe3i8l73n9ijqjdbasgfok